Skip to content
★ Sign in to follow
AB

Anna-Karin Bengtsson

Nanologica AB (publ)
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€25k
▼ Sales (0 ops.)
—

Latest filing published 29 Jun 2021 for Nanologica AB (publ), €16k.

Filing timeline

BuySale
Anna-Karin Bengtsson

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Anna-Karin Bengtsson: trading record in brief

Anna-Karin Bengtsson discloses dealings in Nanologica AB (publ) to Finansinspektionen. The record holds 2 filings, all for trades on 6 April 2020.

Every open-market trade on record is a purchase: 2 purchases worth €25k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2021 alone, the filings show 1 purchase and no sales.

Most recently, on 29 June 2021, the filings show an open-market purchase worth €16k in Nanologica AB (publ). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Anna-Karin Bengtsson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Director Drug DevelopmentExecutivesNanologica AB (publ)
    170,000 SEK0FI-SE
    17,000 shares@ SEK 10.00AktieISIN SE0013914157FI:csv-24faa40c0ffc80e2c525
    Canonical exit: 5 Jul 2020 (T+90)
  • ▲
    Director Drug DevelopmentExecutivesNanologica AB (publ)
    100,000 SEK0FI-SE
    10,000 shares@ SEK 10.00AktieISIN SE0013914157FI:csv-6d0d9e42de8226ffac4f
    Canonical exit: 5 Jul 2020 (T+90)

2 of 2 declarations